CAD/CAM Endocrown for Nonvital Teeth
Trial Summary
What is the purpose of this trial?
This trial studies a new type of dental crown made from strong material, designed in the dentist's office, for patients with root canal-treated teeth. The crown uses the tooth's internal structure for support and is bonded with adhesive, making it less invasive and quicker to apply.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment CEREC Tessera for nonvital teeth?
Is the CAD/CAM Endocrown treatment safe for humans?
The CAD/CAM Endocrown treatment, including versions like CEREC Tessera, has been studied for safety in humans. Clinical studies show a high survival rate of these crowns over several years, with some cases of fractures but no significant safety concerns reported. Overall, the treatment is considered reliable and safe for restoring nonvital teeth.12456
How does the treatment CEREC Tessera differ from other treatments for nonvital teeth?
CEREC Tessera is unique because it uses advanced CAD/CAM technology to create endocrowns, which are custom-fitted crowns that extend into the tooth's pulp chamber, providing a strong and precise fit. This method offers a promising alternative to traditional crowns, with good aesthetic and functional results, and a high survival rate over several years.12367
Research Team
Dennis Fasbinder, DDS
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for adults over 18 needing a final tooth restoration after molar root canal therapy. It's not for those with uncontrolled teeth grinding, pregnant or lactating women, people who can't commit to a 5-year study, or have certain dental conditions like untreated disease, symptoms of tooth fracture, or complications from previous root treatments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive endocrown restorations using chairside CAD/CAM technology, which are adhesively bonded to the tooth
Follow-up
Participants are monitored for restoration failure, margin staining, and loss of retention over five years
Treatment Details
Interventions
- CEREC Tessera
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Dentsply Sirona Implants and Consumables
Industry Sponsor
Simon Campion
Dentsply Sirona Implants and Consumables
Chief Executive Officer since 2022
PhD in Chemistry from Texas A&M University
Dr. Patrizia Cavazzoni
Dentsply Sirona Implants and Consumables
Chief Medical Officer
MD from Harvard Medical School
Dentsply Sirona Implants
Industry Sponsor
Simon Campion
Dentsply Sirona Implants
Chief Executive Officer since 2022
PhD in Chemistry from Texas A&M University
Dr. David Ferguson
Dentsply Sirona Implants
Chief Medical Officer
MD from Harvard Medical School